Please click on the SEARCH button above to search & filter results. To clear and start a new search use the CLEAR button.

For search tips, please click the “?” icon located on the right side of the page.

Browsing Over 592 Sessions

Year in Review

A1 - CLINICAL YEAR IN REVIEW 1

05/21/2017
09:15 AM - 11:15 AM
Hall E (Middle Building, Level 2), Walter E. Washington Convention Center
The annual Clinical Year in Review symposia topics are reviews of key clinical research publications over the last year. Each speaker is asked to review the 5-7 most important and influential publications on their topic in the prior year.
Professional Accreditation
2 CME/2 MOC/2.4 Nursing CE
Show details   Hide details  

Clinical Topics in Pulmonary Medicine

A3 - FELLOWS CASE CONFERENCE

05/21/2017
09:15 AM - 11:15 AM
Ballroom C (South Building, Level 3), Walter E. Washington Convention Center
This session will consist of unique cases presented and discussed by fellows with a panel of clinical experts to moderate the discussion and provide commentary. The cases will provide new insights into disease pathogenesis, diagnosis, and/or treatment. Selected cases will include clear clinical teaching points with review of associated pathology and radiology as appropriate. Finally, the discussion will highlight medical decision making important for both physicians-in-training and seasoned clinicians.
Professional Accreditation
2 CME
Show details   Hide details  

Critical Care Track

A4 - DETERMINANTS OF LONG-TERM OUTCOMES AMONG CRITICALLY ILL OLDER ADULTS: FROM CELL TO POPULATION

05/21/2017
09:15 AM - 11:15 AM
Room 146 A-B (Middle Building, Street Level), Walter E. Washington Convention Center
Older adults comprise the majority of patients admitted to ICUs each year. The aging population and improved survival from critical illness is expected to drive a significant increase in the number of older ICU survivors with life-altering physical and cognitive impairments. This session will explore age-related biological processes and clinical factors that affect long-term outcomes from a clinical and translational science perspective, including ways to enhance care for critically ill older adults. Finally, this session will explore the role of aging-related research in understanding outcomes after critical illness and introduce attendees to research programs from the National Institute on Aging.
Professional Accreditation
2 CME/2 MOC
Show details   Hide details  

Basic Science Core

A5 - DOHAD: DEVELOPMENTAL ORIGINS OF HEALTH AND DISEASE AND THE CIRCLE OF LIFE FOR LUNG DISEASE

05/21/2017
09:15 AM - 11:15 AM
Independence Ballroom E-H (Level M4), Marriott Marquis Washington
The developmental origins of health and disease theory is based on evidence that a suboptimal environment during fetal and neonatal development can impact the evolution of adult-onset disease. A compromised prenatal (and early postnatal) environment leads to increased risk of a number of chronic diseases. DOHaD research is only just emerging as a significant force with respect to lung health and disease. This session will highlight fundamental elements of the DOHaD theory, leveraging examples of significant advances in other disease areas, as well as presenting current significant advances being made with respect to an array of lung disorders.
Professional Accreditation
2 CME
Show details   Hide details  

Scientific Symposium

A6 - BARBARIANS AT THE GATE: VIRUSES AND THE AIRWAY EPITHELIUM IN ASTHMA

05/21/2017
09:15 AM - 11:15 AM
Ballroom A (South Building, Level 3), Walter E. Washington Convention Center
Viral respiratory infections are the most common causes of wheezing in infants and young children and are associated with an increased risk of developing childhood asthma. In addition, viral respiratory infections are common triggers of asthma exacerbations in adult and pediatric patients with pre-existing asthma. The mechanisms by which viral respiratory infections increase future risk of asthma and cause asthma exacerbations are uncertain. Investigators in the NIAID-funded Asthma and Allergic Disease Cooperative Research Center (AADCRC) shed light on these mechanisms through basic, translational and clinical investigation. These studies have yielded new insights into the central role of viral infection in the pathogenesis of asthma and the role that the airway epithelium plays in mediating host-virus interactions. This symposium will present these new discoveries and place them in the context of human disease.
Professional Accreditation
2 CME
Show details   Hide details  

Scientific Symposium

A7 - HOT TOPICS IN PULMONARY REHABILITATION: A PRO/CON DEBATE

05/21/2017
09:15 AM - 11:15 AM
Room 143 A-C (Middle Building, Street Level), Walter E. Washington Convention Center
There are ongoing controversial issues in pulmonary rehabilitation medicine that significantly impact the overall approach to the care of patients with chronic pulmonary disease. This symposium will explore these knowledge gaps through the vehicle of the pro/con debate. The specific topics will be debated by an international faculty of experts who will provide balanced and evidence-based information regarding these controversial areas to guide and improve current clinical practice.
Professional Accreditation
2 CME/2.4 Nursing CE
Show details   Hide details  

Scientific Symposium

A8 - A PRO/CON DEBATE: CONTROVERSIES IN PAH PATHOGENESIS

05/21/2017
09:15 AM - 11:15 AM
Liberty Ballroom I-L (Level M4), Marriott Marquis Washington
This session will focus on controversies in the understanding of the pathogenesis of pulmonary arterial hypertension (PAH). By employing a pro/con debate style, this session will critically evaluate opposing views of how pulmonary hypertension develops, identify points of agreement and disagreement with the ultimate goal to reach a consensus to identify novel treatment targets for PAH.
Professional Accreditation
2 CME
Show details   Hide details  

Scientific Symposium

A9 - IN MEMORY OF PETER T. MACKLEM: EMERGENT PHENOMENA AND HETEROGENEITY IN RESPIRATORY DISEASE

05/21/2017
09:15 AM - 11:15 AM
Marquis Ballroom 5 (Level M2), Marriott Marquis Washington
Lung environment interactions have the potential to trigger seemingly small changes in the lung, which may have much greater impact on the lung through Emergent Phenomena. Expanding on Peter Macklem's article “Emergent phenomena and the secrets of life” (J. Appl.Physiol., 104: 1844-1846, 2008), the session will review key concepts of emergent behavior where the spontaneous development of self-organized order among ensembles occurs, resulting in patterns that can be neither predicted nor explained by examining the isolated components. The session will explore the role of emergent phenomena in health and disease processes such as asthma, breathing during sleep, and pulmonary arterial hypertension.
Professional Accreditation
2 CME
Show details   Hide details  

Scientific Symposium

A10 - A PRO/CON DEBATE IN PEDIATRIC ASTHMA

05/21/2017
09:15 AM - 11:15 AM
Ballroom B (South Building, Level 3), Walter E. Washington Convention Center
This pro/con session will review the evidence on four current controversies in pediatric asthma: 1) Early environmental allergen exposure prevents asthma; 2) Vitamin D supplementation should be a part of asthma management; 3) FeNO should be a standard part of asthma monitoring; and 4) Intermittent ICS is preferred therapy for preschool children with intermittent asthma. Each speaker will review current literature as they present their argument either for or against the topic statement.
Professional Accreditation
2 CME/2.4 Nursing CE
Show details   Hide details  

Scientific Symposium

A11 - LUNG CANCER SCREENING AND TOBACCO CESSATION: THE TEACHABLE MOMENT?

05/21/2017
09:15 AM - 11:15 AM
Independence Ballroom A-D (Level M4), Marriott Marquis Washington
Smoking cessation treatment in conjunction with lung cancer screening offers the opportunity to reduce smoking related mortality. The best approach for delivering interventions in this setting is not known. The session will focus on 5 areas: (1) effect of screening on smoking cessation; (2) minimizing disparities in tobacco treatment within this context; (3) effective smoking cessation interventions specific to screening; (4) message framing to optimize cessation in this setting; (5) applying science to regulatory decision making. We will discuss clinical guidelines, highlight the evidence, address research gaps, and outline stakeholder recommendations for future research.
Professional Accreditation
2 CME/2 MOC/2.4 Nursing CE
Show details   Hide details